Logo image of BZ

KANZHUN LTD - ADR (BZ) Stock Fundamental Analysis

NASDAQ:BZ - Nasdaq - US48553T1060 - ADR - Currency: USD

18.52  -0.43 (-2.27%)

After market: 18.52 0 (0%)

Fundamental Rating

6

Overall BZ gets a fundamental rating of 6 out of 10. We evaluated BZ against 70 industry peers in the Interactive Media & Services industry. While BZ has a great health rating, its profitability is only average at the moment. BZ has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BZ had positive earnings in the past year.
In the past year BZ had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BZ reported negative net income in multiple years.
Each year in the past 5 years BZ had a positive operating cash flow.
BZ Yearly Net Income VS EBIT VS OCF VS FCFBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

BZ has a better Return On Assets (9.11%) than 87.14% of its industry peers.
BZ's Return On Equity of 11.72% is amongst the best of the industry. BZ outperforms 84.29% of its industry peers.
The Return On Invested Capital of BZ (8.29%) is better than 82.86% of its industry peers.
Industry RankSector Rank
ROA 9.11%
ROE 11.72%
ROIC 8.29%
ROA(3y)5.02%
ROA(5y)-3.62%
ROE(3y)6.59%
ROE(5y)-5.82%
ROIC(3y)N/A
ROIC(5y)N/A
BZ Yearly ROA, ROE, ROICBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

With an excellent Profit Margin value of 24.53%, BZ belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
With an excellent Operating Margin value of 19.92%, BZ belongs to the best of the industry, outperforming 87.14% of the companies in the same industry.
BZ has a Gross Margin of 83.43%. This is in the better half of the industry: BZ outperforms 80.00% of its industry peers.
BZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.92%
PM (TTM) 24.53%
GM 83.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.49%
GM growth 5Y-0.72%
BZ Yearly Profit, Operating, Gross MarginsBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BZ is still creating some value.
The number of shares outstanding for BZ has been reduced compared to 1 year ago.
Compared to 5 years ago, BZ has more shares outstanding
BZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BZ Yearly Shares OutstandingBZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BZ Yearly Total Debt VS Total AssetsBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

There is no outstanding debt for BZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.05
WACC7.91%
BZ Yearly LT Debt VS Equity VS FCFBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

BZ has a Current Ratio of 3.56. This indicates that BZ is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.56, BZ is doing good in the industry, outperforming 74.29% of the companies in the same industry.
A Quick Ratio of 3.56 indicates that BZ has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.56, BZ is doing good in the industry, outperforming 74.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.56
Quick Ratio 3.56
BZ Yearly Current Assets VS Current LiabilitesBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5B 10B 15B

6

3. Growth

3.1 Past

BZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.11%, which is quite impressive.
The Revenue has grown by 18.77% in the past year. This is quite good.
The Revenue has been growing by 49.09% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)20.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.76%
Revenue 1Y (TTM)18.77%
Revenue growth 3Y19.98%
Revenue growth 5Y49.09%
Sales Q2Q%12.88%

3.2 Future

The Earnings Per Share is expected to decrease by -2.51% on average over the next years.
BZ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.96% yearly.
EPS Next Y26.19%
EPS Next 2Y19.98%
EPS Next 3Y17.98%
EPS Next 5Y-2.51%
Revenue Next Year11.96%
Revenue Next 2Y12.59%
Revenue Next 3Y12.35%
Revenue Next 5Y11.96%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BZ Yearly Revenue VS EstimatesBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
BZ Yearly EPS VS EstimatesBZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

BZ is valuated rather expensively with a Price/Earnings ratio of 20.35.
65.71% of the companies in the same industry are more expensive than BZ, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.41. BZ is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 15.45, BZ is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BZ indicates a somewhat cheap valuation: BZ is cheaper than 71.43% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.19, BZ is valued rather cheaply.
Industry RankSector Rank
PE 20.35
Fwd PE 15.45
BZ Price Earnings VS Forward Price EarningsBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BZ is valued a bit cheaper than the industry average as 67.14% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BZ is valued a bit cheaper than 67.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.14
EV/EBITDA 15.89
BZ Per share dataBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of BZ may justify a higher PE ratio.
BZ's earnings are expected to grow with 17.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.78
PEG (5Y)N/A
EPS Next 2Y19.98%
EPS Next 3Y17.98%

0

5. Dividend

5.1 Amount

BZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KANZHUN LTD - ADR

NASDAQ:BZ (7/11/2025, 8:00:02 PM)

After market: 18.52 0 (0%)

18.52

-0.43 (-2.27%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)05-22 2025-05-22/bmo
Earnings (Next)08-26 2025-08-26/bmo
Inst Owners83.68%
Inst Owner Change0.02%
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap8.20B
Analysts83.57
Price Target21.41 (15.6%)
Short Float %9.14%
Short Ratio5.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.21%
Min EPS beat(2)-0.61%
Max EPS beat(2)7.02%
EPS beat(4)3
Avg EPS beat(4)4.46%
Min EPS beat(4)-0.61%
Max EPS beat(4)9.37%
EPS beat(8)7
Avg EPS beat(8)17.79%
EPS beat(12)10
Avg EPS beat(12)267.57%
EPS beat(16)14
Avg EPS beat(16)218.76%
Revenue beat(2)0
Avg Revenue beat(2)-2.32%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)-2.27%
Revenue beat(4)0
Avg Revenue beat(4)-2.32%
Min Revenue beat(4)-3.05%
Max Revenue beat(4)-1.57%
Revenue beat(8)2
Avg Revenue beat(8)-1.19%
Revenue beat(12)3
Avg Revenue beat(12)-1.13%
Revenue beat(16)5
Avg Revenue beat(16)-0.81%
PT rev (1m)0.8%
PT rev (3m)1.19%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.22%
EPS NY rev (1m)1.58%
EPS NY rev (3m)1.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.06%
Valuation
Industry RankSector Rank
PE 20.35
Fwd PE 15.45
P/S 7.75
P/FCF 16.14
P/OCF 16.14
P/B 3.7
P/tB 3.76
EV/EBITDA 15.89
EPS(TTM)0.91
EY4.91%
EPS(NY)1.2
Fwd EY6.47%
FCF(TTM)1.15
FCFY6.2%
OCF(TTM)1.15
OCFY6.2%
SpS2.39
BVpS5
TBVpS4.92
PEG (NY)0.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.11%
ROE 11.72%
ROCE 9.44%
ROIC 8.29%
ROICexc 110.69%
ROICexgc 139.95%
OM 19.92%
PM (TTM) 24.53%
GM 83.43%
FCFM 48.05%
ROA(3y)5.02%
ROA(5y)-3.62%
ROE(3y)6.59%
ROE(5y)-5.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.49%
GM growth 5Y-0.72%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 181.01%
Profit Quality 195.93%
Current Ratio 3.56
Quick Ratio 3.56
Altman-Z N/A
F-Score8
WACC7.91%
ROIC/WACC1.05
Cap/Depr(3y)260.87%
Cap/Depr(5y)288.66%
Cap/Sales(3y)11.74%
Cap/Sales(5y)9.69%
Profit Quality(3y)326.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.76%
EPS Next Y26.19%
EPS Next 2Y19.98%
EPS Next 3Y17.98%
EPS Next 5Y-2.51%
Revenue 1Y (TTM)18.77%
Revenue growth 3Y19.98%
Revenue growth 5Y49.09%
Sales Q2Q%12.88%
Revenue Next Year11.96%
Revenue Next 2Y12.59%
Revenue Next 3Y12.35%
Revenue Next 5Y11.96%
EBIT growth 1Y98.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.36%
EBIT Next 3Y25.42%
EBIT Next 5Y18.71%
FCF growth 1Y190.53%
FCF growth 3Y24.82%
FCF growth 5YN/A
OCF growth 1Y190.53%
OCF growth 3Y29.23%
OCF growth 5YN/A